Endovascular Recanalization of Symptomatic Intracranial Arterial Stenosis Despite Aggressive Medical Management.


Journal

World neurosurgery
ISSN: 1878-8769
Titre abrégé: World Neurosurg
Pays: United States
ID NLM: 101528275

Informations de publication

Date de publication:
Mar 2019
Historique:
received: 27 08 2018
revised: 03 12 2018
accepted: 04 12 2018
pubmed: 24 12 2018
medline: 2 4 2019
entrez: 22 12 2018
Statut: ppublish

Résumé

The optimal management of intracranial arterial stenosis is unclear, particularly in patients who have failed medical management. We report a multicenter real-world experience of endovascular recanalization of intracranial atherosclerotic stenosis refractory to aggressive medical therapy. Retrospective multicenter case series of consecutive endovascularly treated patients presenting with symptomatic (transient ischemic attack [TIA] or stroke) intracranial stenosis who had failed medical therapy. Patients were divided into 2 groups: patients with recurrent TIA or stroke despite medical management (group 1) versus patients presenting with a stroke and worsening symptoms (progressive or crescendo stroke) despite medical management (group 2). A total of 101 patients were treated in 8 stroke centers from August 2009 to May 2017. Sixty-nine presented with recurrent TIA or stroke and 32 with stroke and worsening symptoms. Successful recanalization was achieved in 84% of patients. Periprocedural stroke occurred in 3 patients and 2 had a recurrent ischemic stroke at the 90-day follow-up. Symptomatic intraparenchymal hemorrhage secondary to reperfusion injury occurred in 3 patients and 1 had a hemorrhagic stroke after discharge. There were 2 periprocedural perforations that resulted in death. At 90 days, 86% of patients (64/74) did not have a recurrence of stroke and the 90-day cumulative ischemic stroke rate was 6.7% with 90-day mortality of 11.2%. The 90-day favorable outcome (modified Rankin Scale score, ≤2) rate was 77.5%. Endovascular recanalization of unstable intracranial atherosclerotic stenosis in patients who have failed medical therapy is feasible. Future randomized trials need to determine if recanalization is of any value for this population.

Sections du résumé

BACKGROUND BACKGROUND
The optimal management of intracranial arterial stenosis is unclear, particularly in patients who have failed medical management. We report a multicenter real-world experience of endovascular recanalization of intracranial atherosclerotic stenosis refractory to aggressive medical therapy.
METHODS METHODS
Retrospective multicenter case series of consecutive endovascularly treated patients presenting with symptomatic (transient ischemic attack [TIA] or stroke) intracranial stenosis who had failed medical therapy. Patients were divided into 2 groups: patients with recurrent TIA or stroke despite medical management (group 1) versus patients presenting with a stroke and worsening symptoms (progressive or crescendo stroke) despite medical management (group 2).
RESULTS RESULTS
A total of 101 patients were treated in 8 stroke centers from August 2009 to May 2017. Sixty-nine presented with recurrent TIA or stroke and 32 with stroke and worsening symptoms. Successful recanalization was achieved in 84% of patients. Periprocedural stroke occurred in 3 patients and 2 had a recurrent ischemic stroke at the 90-day follow-up. Symptomatic intraparenchymal hemorrhage secondary to reperfusion injury occurred in 3 patients and 1 had a hemorrhagic stroke after discharge. There were 2 periprocedural perforations that resulted in death. At 90 days, 86% of patients (64/74) did not have a recurrence of stroke and the 90-day cumulative ischemic stroke rate was 6.7% with 90-day mortality of 11.2%. The 90-day favorable outcome (modified Rankin Scale score, ≤2) rate was 77.5%.
CONCLUSIONS CONCLUSIONS
Endovascular recanalization of unstable intracranial atherosclerotic stenosis in patients who have failed medical therapy is feasible. Future randomized trials need to determine if recanalization is of any value for this population.

Identifiants

pubmed: 30576811
pii: S1878-8750(18)32827-4
doi: 10.1016/j.wneu.2018.12.008
pii:
doi:

Types de publication

Evaluation Study Journal Article Multicenter Study

Langues

eng

Sous-ensembles de citation

IM

Pagination

e693-e699

Informations de copyright

Copyright © 2018 Elsevier Inc. All rights reserved.

Auteurs

Amin Aghaebrahim (A)

Lyerly Neurosurgery/Baptist Health, Baptist Neurological Institute, Jacksonville, Florida, USA. Electronic address: Amin.Aghaebrahim@bmcjax.com.

Guilherme Jose Agnoletto (GJ)

Lyerly Neurosurgery/Baptist Health, Baptist Neurological Institute, Jacksonville, Florida, USA.

Pedro Aguilar-Salinas (P)

Lyerly Neurosurgery/Baptist Health, Baptist Neurological Institute, Jacksonville, Florida, USA.

Manuel F Granja (MF)

Lyerly Neurosurgery/Baptist Health, Baptist Neurological Institute, Jacksonville, Florida, USA.

Andre Monteiro (A)

Lyerly Neurosurgery/Baptist Health, Baptist Neurological Institute, Jacksonville, Florida, USA.

Adnan H Siddiqui (AH)

Department of Neurosurgery and Toshiba Stroke Research Center, University at Buffalo, Buffalo, New York, USA.

Elad I Levy (EI)

Department of Neurosurgery and Toshiba Stroke Research Center, University at Buffalo, Buffalo, New York, USA.

Hussain Shallwani (H)

Department of Neurosurgery and Toshiba Stroke Research Center, University at Buffalo, Buffalo, New York, USA.

Song J Kim (SJ)

Department of Neurology, Grady Memorial Hospital/Emory University School of Medicine, Atlanta, Georgia, USA.

Diogo C Haussen (DC)

Department of Neurology, Grady Memorial Hospital/Emory University School of Medicine, Atlanta, Georgia, USA.

Raul G Nogueira (RG)

Department of Neurology, Grady Memorial Hospital/Emory University School of Medicine, Atlanta, Georgia, USA.

Demetrius Lopes (D)

Department of Neurosurgery, Rush University Medical Center, Chicago, Illinois, USA.

Ahmed Saied (A)

Department of Neurosurgery, Rush University Medical Center, Chicago, Illinois, USA.

Tudor G Jovin (TG)

Department of Neurology, University of Pittsburgh Medical Center, Pittsburgh, Pennsylvania, USA.

Ashutosh P Jadhav (AP)

Department of Neurology, University of Pittsburgh Medical Center, Pittsburgh, Pennsylvania, USA.

Kaustubh Limaye (K)

Department of Neurology, University of Pittsburgh Medical Center, Pittsburgh, Pennsylvania, USA.

Aquilla S Turk (AS)

Department of Neurosurgery, Medical University of South Carolina, Charleston, South Carolina, USA.

Alejandro M Spiotta (AM)

Department of Neurosurgery, Medical University of South Carolina, Charleston, South Carolina, USA.

Mohammad I Chaudry (MI)

Department of Neurosurgery, Medical University of South Carolina, Charleston, South Carolina, USA.

Raymond D Turner (RD)

Department of Neurosurgery, Medical University of South Carolina, Charleston, South Carolina, USA.

Leonardo B C Brasiliense (LBC)

Division of Neurosurgery, University of Arizona, Tucson, Arizona, USA.

Travis M Dumont (TM)

Division of Neurosurgery, University of Arizona, Tucson, Arizona, USA.

Jacob Cherian (J)

Department of Neurosurgery, Baylor College of Medicine, Houston, Texas, USA.

Peter Kan (P)

Department of Neurosurgery, Baylor College of Medicine, Houston, Texas, USA.

Eric Sauvageau (E)

Lyerly Neurosurgery/Baptist Health, Baptist Neurological Institute, Jacksonville, Florida, USA.

Ricardo A Hanel (RA)

Lyerly Neurosurgery/Baptist Health, Baptist Neurological Institute, Jacksonville, Florida, USA.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH